The financial burden of chronic wounds in primary care: A real-world data analysis on cost and prevalence
- PMID: 40535786
- PMCID: PMC12175658
- DOI: 10.1016/j.ijnsa.2025.100313
The financial burden of chronic wounds in primary care: A real-world data analysis on cost and prevalence
Abstract
Background: Chronic wounds place a substantial clinical and economic burden on health systems and significantly reduce the quality of life of those affected. However, there are no large-scale economic evaluations to assess costs based on data in a real-world environment.
Objective: We aimed to analyse the costs of managing patients with chronic wounds (pressure injuries, ulcers of venous aetiology, ulcers of arterial aetiology, diabetes-related foot ulcers, and lower-limb ulcers of other aetiologies) in primary care in the southern area of Barcelona, Spain, through a 3-year real-world data analysis.
Methods: The direct costs associated with specific treatment materials and primary care consultations were analysed using the electronic clinical records and financial management data of 54 primary care centres managed by the Catalan Institute of Health, which served a population ranging from 890,152 in 2015 to 939,747 in 2017.
Results: Between 2015 and 2017, total expenditure was estimated at € 34,991,854 (Euros) (USD 39,548,000 -United States Dollars-). The cost of the specific treatment materials was € 8,455,787 (USD 9,555,885), with an annual average of € 2,818,596 (USD 3,185,295) and an increase of 18.5 % over the period. The cost of the consultations for chronic wound management was € 26,536,067 (USD 29,988,409). The cumulative annual prevalence of chronic wounds per 10,000 inhabitants was 86.70‱ in 2015, 88.03‱ in 2016 and 88.7‱ in 2017. Pressure injuries accounted for 46.39 % to 42.86 % of all chronic wounds. The direct extrapolation of chronic wounds costs to the total population of Spain was € 1,763,037,849 (USD 1,993,409,074) (mean annual average € 587,679,283 -USD 664,136,358-) during the study period, with a prevalence of 388,777 and an estimated peak of 413,897 in 2017.
Conclusion: We found that chronic wounds have a significant economic impact and should be considered in the planning and management of healthcare resources to ensure adequate and sustainable primary care services.
Tweetable abstract: Chronic wounds represent a significant clinical and economic burden in medical devices and consultations, costing 34.99 million euros over three years. Effective planning is essential for the sustainability of primary care services.
Keywords: Data analysis; Diabetic foot; Health expenditures; Leg ulcer; Pressure injuries; Prevalence; Primary health care; Ulcers of venous aetiology; Workload.
© 2025 The Author(s).
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Prevalence of chronic wounds in hospitalised patients in Catalonia, Spain: a multicentre cross-sectional descriptive observational study.BMJ Open. 2025 May 28;15(5):e095542. doi: 10.1136/bmjopen-2024-095542. BMJ Open. 2025. PMID: 40441765 Free PMC article.
-
The Out-of-Pocket Cost Burden of Cancer Care-A Systematic Literature Review.Curr Oncol. 2021 Mar 15;28(2):1216-1248. doi: 10.3390/curroncol28020117. Curr Oncol. 2021. PMID: 33804288 Free PMC article.
-
Cost-effectiveness of enzalutamide with androgen-deprivation therapy (ADT) versus ADT alone for the treatment of high-risk biochemically recurrent non-metastatic castration-sensitive prostate cancer in Canada.J Med Econ. 2025 Dec;28(1):766-777. doi: 10.1080/13696998.2025.2503660. Epub 2025 May 23. J Med Econ. 2025. PMID: 40395149
-
Prevalence and odds of anxiety and depression in cutaneous malignant melanoma: a proportional meta-analysis and regression.Br J Dermatol. 2024 Jun 20;191(1):24-35. doi: 10.1093/bjd/ljae011. Br J Dermatol. 2024. PMID: 38197404
-
Cost-of-illness and Economic Evaluation of Interventions in Children and Adolescents With Chronic Pain: A Systematic Review.Clin J Pain. 2024 May 1;40(5):306-319. doi: 10.1097/AJP.0000000000001199. Clin J Pain. 2024. PMID: 38268231 Free PMC article.
References
-
- Agència de Qualitat i Avaluació Sanitàries de Catalunya, n.d. Dades anteriors. Observatori del Sistema de Salut de Catalunya [WWW Document]. URL https://observatorisalut.gencat.cat/ca/central_de_resultats/informes_cdr...(accessed 11.7.22).
-
- Bundó M., Vlacho B., Llussà J., Puig-Treserra R., Mata-Cases M., Cos X., Jude E.B., Franch-Nadal J., Mauricio D. Prevalence and risk factors of diabetic foot disease among the people with type 2 diabetes using real-world practice data from Catalonia during 2018. Front. Endocrinol. (Lausanne) 2022;13:1–10. doi: 10.3389/fendo.2022.1024904. - DOI - PMC - PubMed
-
- Catalunya G.de. Idescat. Estructura. Índex de preus de consum (IPC) Resultats. 2018 https://www.idescat.cat/indicadors/?id=anuals&n=10469 URL. (accessed 9.14.22)